Orphazyme A/S, of Copenhagen, Denmark, disclosed the creation of a U.S. subsidiary, based in Newton, Mass., called Orphazyme U.S. Inc., which will directly support the U.S. market and work to establish closer relationships with the medical, patient and financial communities.